Jump to main content.

Note: EPA no longer updates this information, but it may be useful as a reference or resource.

Draft Agenda
Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC)
Ninth and Final Plenary

June 17-18, 1998
Capital Hilton
Washington, D.C.

Wednesday, June 17, 1998

8:30 a.m. Coffee Available
9:00 a.m. Welcome and Preliminaries
 
  • Agenda Review

  • Overview of EDSTAC Efforts Since Last Meeting

9:15 a.m. Brief Discussion of the Report Layout
9:30 a.m. Overview of Changes to Chapter Four: Priority Setting
9:45 a.m. Discussion of Key Priority Setting Issues, Possibly Including:
 
  • revised description of the universe of chemicals to be considered for screening and testing (Section I. B.);

  • revisions to Figure 4.1;

  • new language to describe the phased approach to implementation and the reference to 60,000 chemicals (Sections II. B. and II. F.);

  • rationale for pesticides going through high throughput pre-screening (Sections II. I. and V. G. 2.);

  • the handling of mixtures (Section VII. F. 4);

  • revisions to description of the nominations vis-à-vis protection of the identity of the nominator (Section IX. D.)

  • clarifications regarding the role of the recommended multi-stakeholder follow-up process vis-à-vis the data base tool (Section X. G.);

  • revisions to the explanation of the compartmental approach to priority setting (Section XI. F.);

  • revisions to the explanation of the recommended approach to priority setting for T2T (Section XI. H.); and

  • any other substantive changes to Chapter Four not covered in this list.

10:30 a.m. Break
10:45 a.m. Continued Discussion of Priority Setting Issues
12:00 noon Lunch
1:15 p.m. Overview of Changes to Chapter Five, Screening and Testing
1:30 p.m. Discussion of Key Screening and Testing Issues, Possibly Including:
 
  • revisions to the section on embryonic exposure in T1S (III. A. 5);

  • the methods to select the single dose (III. A. 6);

  • revisions to the introduction to T2T (V. A.);

  • the new background and context within which T2T will be conducted section (V. B.);

  • revised guidance for selecting Tier 2 Tests (V. D.);

  • the new recommended research program to address low dose issues (V. E. 2);

  • revisions to Table 5.3;

  • revisions to the alternative approaches to mammalian T2T (VI. C.);

  • removal of what was Section VII., regarding interconnections;

  • revisions to the levels of effort to validate the recommended screens and tests (VIII. E.); and

  • any other substantive changes to Chapter Five not covered in this list.

3:00 p.m. Break
3:15 p.m. Overview and Discussion of Changes to Chapter Six: Communications and Outreach, Possibly Including:
 

  • revisions to the "What Should be Communicated" section, including "boilerplate" language (III. B. 1); and

  • revisions to the recommendation for a tracking database (III. B. 3).

4:15 p.m. Overview and Discussion of Changes to Chapter Seven: Implementation
5:00 p.m. Overview and Discussion of Chapter Eight: Summary of Recommendations
5:30 p.m. Adjourn for Dinner

[As Noted in the cover memo: We have not scheduled time for full plenary discussions during the evening; however, small groups, or possibly even the full plenary, may need to spend time together to address issues raised during the first day of deliberations.]

Thursday, June 18, 1998

8:00 a.m. Coffee Available
8:30 a.m. Revisit and Resolve any Priority Setting and Screening and Testing Issues not Completed the Previous Day
10:15 a.m. Break
10:30 a.m. Overview and Approval of Changes to Chapter Three, Conceptual Framework; Discuss and Resolve Language Related to the Description of Endocrine Disruptor
11:00 a.m. Overview and Approval of Changes to Chapter Two, Background
11:45 a.m. Overview and Approval of Chapter One, Introduction, Including Any Changes That May Be Necessary to Properly Characterize the Outcome of the EDSTAC Process
12:30 p.m. Lunch
1:30 p.m. Overview, Discussion, and Approval of the Executive Summary
2:45 p.m. Break
3:00 p.m. Revisit of Outstanding Issues
3:30 p.m. Award Ceremony
4:00 p.m. Adjourn and ...

Local Navigation

Jump to main content.